The high expression of the NUSAP1 gene has been associated with poor prognosis in melanoma patients [3], with a malignancy-risk genetic signature in breast cancer [4] and with recurrence in prostate cancer [15]. This evidence concerns the gene NUSAP1 and prostate carcinoma.